NasdaqGS - Nasdaq Real Time Price USD
Centessa Pharmaceuticals plc (CNTA)
11.86
-0.06
(-0.50%)
As of 3:32:43 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ANDERSON KAREN M Officer | Sale | Feb 10, 2025 | 54,322 |
BUSH TIA L Chief Technology Officer | Sale | Feb 3, 2025 | 121,503 |
CHAO DAVID M Officer | Sale | Mar 17, 2025 | 225,007 |
GOYAL ARJUN Director | Purchase | May 16, 2025 | -- |
HUSSAIN IQBAL J General Counsel | Sale | May 1, 2025 | 110,886 |
ROTMAN HARRIS Officer | Sale | Feb 1, 2024 | 62,625 |
SAHA SAURABH Chief Executive Officer | Sale | May 20, 2025 | 259,017 |
WEINHOFF GREGORY M Officer | Sale | May 27, 2025 | 122,279 |
Related Tickers
UPB Upstream Bio, Inc.
11.38
+0.98%
COGT Cogent Biosciences, Inc.
6.87
+1.03%
CRNX Crinetics Pharmaceuticals, Inc.
32.39
-1.89%
SYRE Spyre Therapeutics, Inc.
17.22
+1.47%
TRML Tourmaline Bio, Inc.
19.04
-1.22%
CGEM Cullinan Therapeutics, Inc.
8.76
-3.58%
NRIX Nurix Therapeutics, Inc.
12.64
-1.10%
TECX Tectonic Therapeutic, Inc.
24.19
+4.88%
TRVI Trevi Therapeutics, Inc.
6.51
-7.86%
BCAX Bicara Therapeutics Inc.
11.46
-0.39%